InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD.
The company and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD.
CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells.
This product, which is expected to be administered by inhalation, will be tested against a variety of lung infections.